Acer Therapeutics Inc. (ACER) Financials

NASDAQ Currency in USD Disclaimer

$0.66

north_east NA Past Year
Day's range
$0.66
Day's range
$0.85
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning2016201620172017201820182019201920202020202120212022202215000%15000%10000%10000%5000%5000%0%0%-5000%-5000%Profit Margin
Profit Margin
Revenue
Earnings

ACER Income statement / Annual

Last year (2022), Acer Therapeutics Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2022, Acer Therapeutics Inc.'s net income was -$27.86 M. See Acer Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $0.00 $1.26 M $0.00 $0.00 $432,116.00 -$246,304.00 $2.91 M $2.56 M $1.27 M $1.27 M
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $1.26 M $0.00 $0.00 $432,116.00 -$246,304.00 $2.91 M $2.56 M $1.27 M $1.27 M
Gross Profit Ratio 0 1 0 0 1 1 1 1 1 1
Research and Development Expenses $11.92 M $6.51 M $11.85 M $13.85 M $12.45 M $8.73 M $6.50 M $10.04 M $12.12 M $9.18 M
General & Administrative Expenses $12.69 M $10.70 M $10.95 M $16.05 M $9.26 M $5.22 M $3.12 M $4.26 M $3.83 M $3.67 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.69 M $10.70 M $10.95 M $16.05 M $9.26 M $5.22 M $3.12 M $4.26 M $3.83 M $3.67 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10,629.00 $68,695.00 $2,147.00 $37,910.00
Operating Expenses $24.61 M $17.21 M $22.80 M $29.90 M $21.71 M $13.95 M $9.86 M $14.65 M $16.34 M $13.19 M
Cost And Expenses $24.61 M $17.21 M $22.80 M $29.90 M $21.71 M $13.95 M $9.86 M $14.65 M $16.34 M $13.19 M
Interest Income $1,821.53 $49.27 $13,578.00 $471,267.00 $412,553.00 $14,848.00 $0.00 $0.00 $15,456.00 $14,985.00
Interest Expense $101,432.00 $0.00 $0.00 $0.00 $987.00 $245,061.00 $0.00 $0.00 $1,983.00 $2.27 M
Depreciation & Amortization -$198,470.00 -$54,757.00 $96,202.00 -$8,205.00 $27,744.00 $3,997.00 $238,127.00 $351,403.00 $387,779.00 $335,597.00
EBITDA -$24.55 M -$15.88 M -$22.73 M -$28.34 M -$21.25 M -$13.95 M -$6.70 M -$2.57 M -$14.66 M -$11.53 M
EBITDA Ratio 0 -12.7 0 0 -49.29 56.57 -1.95 -4.59 -11.53 -9.1
Operating Income Ratio 0 -12.66 0 0 -50.25 56.63 -2.75 -4.73 -11.85 -9.41
Total Other Income/Expenses Net -$1.62 M $574,396.00 -$82,624.00 -$1.02 M $433,103.00 -$246,304.00 -$1.28 M $74,606.00 $15,620.00 -$4.73 M
Income Before Tax -$26.24 M -$15.37 M -$22.89 M -$29.42 M -$21.28 M -$14.19 M -$7.98 M -$12.02 M -$15.05 M -$16.66 M
Income Before Tax Ratio 0 -12.2 0 0 -49.25 57.63 -2.75 -4.7 -11.83 -13.15
Income Tax Expense $1.62 M -$645,309.00 $11,810.00 -$537,754.00 -$432,116.00 $246,304.00 $1.04 M -$4,744.00 $4,130.00 $2.31 M
Net Income -$27.86 M -$14.73 M -$22.90 M -$28.88 M -$21.28 M -$14.19 M -$7.98 M -$12.02 M -$15.05 M -$16.66 M
Net Income Ratio 0 -11.69 0 0 -49.25 57.63 -2.75 -4.7 -11.83 -13.15
EPS -1.77 -1.03 -2.06 -2.86 -2.49 -3.84 -11.72 -21.26 -39.65 -91.56
EPS Diluted -1.77 -1.03 -2.06 -2.86 -2.49 -3.84 -11.72 -21.26 -39.65 -91.56
Weighted Average Shares Out $15.77 M $14.27 M $11.12 M $10.09 M $8.56 M $3.69 M $680,668.00 $565,345.00 $379,627.00 $181,924.00
Weighted Average Shares Out Diluted $15.77 M $14.27 M $11.12 M $10.09 M $8.56 M $3.69 M $680,668.00 $565,345.00 $379,627.00 $181,924.00
Link